Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cogent Biosciences, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-04-13 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-04-13
Exact text from the filing
Votes For Votes Against Abstentions Broker Non-Votes Proposal 3. Advisory Vote on Executive Compensation 129,183,846 13,977,449 32,606 11,240,612
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cogent Biosciences, Inc. shareholders approved Election of Directors at the 2026-04-13 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-04-13
Exact text from the filing
At the Annual Meeting, each of the Company’s director nominees was elected and each of the other proposals voted on were approved. The final voting results are set forth below. Votes For Votes Withheld Broker Non-Votes Proposal 1. Election of Directors • Chris Cain, Ph.D. 124,356,809 18,837,092 11,240,612 • Arlene Morris 120,180,517 23,013,384 11,240,612 • Todd Shegog 124,143,441 19,050,460 11,240,612
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Cogent Biosciences, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm at the 2026-04-13 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-04-13
Exact text from the filing
Votes For Votes Against Abstentions Broker Non-Votes Proposal 2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 154,001,553 399,367 33,593 0
View on SEC.gov